Dutch immunology company argenx has announced positive top-line data from the pivotal ADAPT SERON Phase III study of Vyvgart ...

The US Food and Drug Administration on Friday revealed it has begun daily publication of adverse event data from the FDA ...

Founded in 2016 and headquartered in San Francisco, Multiply Labs designs robotic manufacturing systems for personalized ...

Shares in Biohaven moved up about 7% on Friday after the company provided an update with respect to its New Drug Application (NDA) for troriluzole for the treatment of adult patients with ...

The US Food and Drug Administration (FDA) granted approval for a second treatment for metabolic dysfunction-associated ...

By a vote of 5-4, the US Supreme Court on Thursday agreed to allow the National Institutes of Health, the largest public ...

The range of drugs available in the Russian market may significantly decrease in the short term due to protectionist measures ...

A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...

US pharma major AbbVie reported positive top-line results from the second of two pivotal studies of the Phase III UP-AA ...

The pharmaceutical industry and the UK government have failed to reach agreement on requested changes to a medicines payment ...

The USA and European Union on Thursday released new details of their trade framework, addressing long-standing disputes and ...

Swiss pharma company Idorsia announced that its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan), has ...